In conclusion, our findings suggest that AKE may prevent UPM exposure-induced KCS, by increasing tear volume, inhibiting damage to the corneal epithelium, decreasing corneal surface irregularity, and attenuating disruption of the mucin-4 layer by inhibiting MMP-9, IL-6, and TNF-α. This evidence concerns the gene MUC4 and dry eye syndrome.